ANTXAN2 Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11749
Ticker: ANTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2022-03-25
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ANTX

Detail

Enriched 2026-08-14 20:47

Market cap: $236,983,568.36
Shares outstanding (class): 36,016,161
Shares outstanding (weighted): 37,736,237
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 21
Location: MENLO PARK, CA
Homepage: https://www.an2therapeutics.com
Description: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $3.86M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$2.51M	0.00%	733,392 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$862.2K	0.00%	252,112 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$201.8K	0.16%	59,000 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$181.8K	0.01%	53,165 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$43.8K	0.00%	12,793 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$43.7K	0.00%	12,781 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$13.4K	0.01%	3,924 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$684.00	0.00%	200 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERANTX
FIGI_COMPOSITEBBG00QYLYBK4
FIGI_SHARE_CLASSBBG00QYLYBL3
CIK0001880438
ISINUS0373261058
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.